Decreased Portal Circulation Augments Fibrosis and Ductular Reaction in Nonalcoholic Fatty Liver Disease in Mice

被引:11
|
作者
Meng, Lingtong [1 ,2 ]
Goto, Masanori [1 ]
Tanaka, Hiroki [1 ]
Kamikokura, Yuki [1 ]
Fujii, Yumiko [1 ]
Okada, Yoko [1 ]
Furukawa, Hiroyuki [2 ]
Nishikawa, Yuji [1 ]
机构
[1] Asahikawa Med Univ, Dept Pathol, Div Tumor Pathol, Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan
[2] Asahikawa Med Univ, Dept Surg, Div Gastroenterol & Gen Surg, Asahikawa, Hokkaido, Japan
来源
AMERICAN JOURNAL OF PATHOLOGY | 2021年 / 191卷 / 09期
基金
日本学术振兴会;
关键词
TISSUE GROWTH-FACTOR; ARTERIAL BUFFER RESPONSE; HEPATIC ARTERIAL; PORTOSYSTEMIC SHUNTS; STEATOHEPATITIS; PROGRESSION; EXPRESSION; CIRRHOSIS; HYPERTENSION; INDUCTION;
D O I
10.1016/j.ajpath.2021.06.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Nonalcoholic fatty liver disease often progresses to cirrhosis and causes liver cancer, but mechanisms of its progression are yet to be elucidated. Although nonalcoholic fatty liver disease is often associated with abnormal portal circulation, there have not been any experimental studies to test its pathogenic role. Here, whether decreased portal circulation affected the pathology of nonalcoholic steatohepatitis (NASH) was examined using congenital portosystemic shunt (PSS) in C57BL/6J mice. Whereas PSS significantly attenuated free radical-mediated carbon tetrachloride injury, it augmented pericellular fibrosis in the centrilobular area induced by a 0.1% methionine choline-deficient L-amino acid-defined high-fat diet (CDAHFD). PSS aggravated ductular reaction and increased the expression of connective tissue growth factor. Pimonidazole immunohistochemistry of the liver revealed that the centrilobular area of PSS-harboring mice was more hypoxic than that of control mice. Although tissue hypoxia was observed in the fibrotic area in CDAHFD-induced NASH in both control and PSS-harboring mice, it was more profound in the latter, which was associated with higher carbonic anhydrase 9 and vascular endothelial growth factor expression and neovascularization in the fibrotic area. Furthermore, partial ligation of the portal vein also augmented pericellular fibrosis and ductular reaction induced by a CDAHFD. These results demonstrate that decreased portal circulation, which induces hypoxia due to disrupted intralobular perfusion, is an important aggravating factor of liver fibrosis in NASH.
引用
收藏
页码:1580 / 1591
页数:12
相关论文
共 50 条
  • [41] Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
    Buzzetti, Elena
    Lombardi, Rosa
    De Luca, Laura
    Tsochatzis, Emmanuel A.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [42] Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
    Kaswala, Dharmesh H.
    Lai, Michelle
    Afdhal, Nezam H.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1356 - 1364
  • [43] Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease
    Malecki, Pawel
    Figlerowicz, Magdalena
    Kemnitz, Pawel
    Mazur-Melewska, Katarzyna
    Sluzewski, Wojciech
    Mania, Anna
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (03) : 220 - 227
  • [44] Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
    Yoneda, Masato
    Fujii, Hideki
    Sumida, Yoshio
    Hyogo, Hideyuki
    Itoh, Yoshito
    Ono, Masafumi
    Eguchi, Yuichiro
    Suzuki, Yasuaki
    Aoki, Noriaki
    Kanemasa, Kazuyuki
    Imajo, Kento
    Chayama, Kazuaki
    Saibara, Toshiji
    Kawada, Norifumi
    Fujimoto, Kazuma
    Kohgo, Yutaka
    Yoshikawa, Toshikazu
    Okanoue, Takeshi
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (11) : 1300 - 1306
  • [45] Pathologic features associated with fibrosis in nonalcoholic fatty liver disease
    Gramlich, T
    Kleiner, DE
    McCullough, AJ
    Matteoni, CA
    Boparai, N
    Younossi, ZM
    HUMAN PATHOLOGY, 2004, 35 (02) : 196 - 199
  • [46] Nonalcoholic Fatty Liver Disease: Fibrosis Portends a Worse Prognosis
    Torres, Dawn M.
    Harrison, Stephen A.
    HEPATOLOGY, 2015, 61 (05) : 1462 - 1464
  • [47] Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
    Masato Yoneda
    Hideki Fujii
    Yoshio Sumida
    Hideyuki Hyogo
    Yoshito Itoh
    Masafumi Ono
    Yuichiro Eguchi
    Yasuaki Suzuki
    Noriaki Aoki
    Kazuyuki Kanemasa
    Kento Imajo
    Kazuaki Chayama
    Toshiji Saibara
    Norifumi Kawada
    Kazuma Fujimoto
    Yutaka Kohgo
    Toshikazu Yoshikawa
    Takeshi Okanoue
    Journal of Gastroenterology, 2011, 46 : 1300 - 1306
  • [48] Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease
    Saumya Jayakumar
    Stephen A. Harrison
    Rohit Loomba
    Current Hepatology Reports, 2016, 15 (2) : 86 - 95
  • [49] Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
    Zein, Claudia O.
    Unalp, Aynur
    Colvin, Ryan
    Liu, Yao-Chang
    McCullough, Arthur J.
    JOURNAL OF HEPATOLOGY, 2011, 54 (04) : 753 - 759
  • [50] SERUM FIBROSIS MARKERS IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE
    Lebensztejn, D. M.
    Wierzbicka, A.
    Socha, P.
    Pronicki, M.
    Skiba, E.
    Werpachowska, I.
    Kaczmarski, M.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E31 - E32